Koninklijke Philips (PHG) Construction in Progress (2016 - 2017)

Koninklijke Philips' (PHG) quarterly Construction in Progress came in at -$806.5 million in Q4 2017, down 0.81% year-on-year from -$813.1 million in Q4 2016, and down 0.81% quarter-over-quarter from -$800.1 million in Q4 2016.

Koninklijke Philips (PHG) Construction in Progress (2016 - 2017) Analysis & Trends

Koninklijke Philips' Construction in Progress history runs 2 years deep, the most recent figure standing at -$806.5 million for Q4 2017.

  • On a quarterly basis, Construction in Progress fell 0.81% year-over-year to -$806.5 million in Q4 2017; TTM through Dec 2017 was -$806.5 million, a 0.81% decrease from a year earlier, with the FY2017 full-year figure at -$806.5 million, up 1.68% from the prior year.
  • Construction in Progress retreated to -$806.5 million in Q4 2017 per PHG's latest filing, from -$800.1 million in the prior quarter.
  • Across five years, Construction in Progress topped out at -$800.1 million in Q4 2016 and bottomed at -$806.5 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Abbott Laboratories 183.74 Bn 176.45 Bn 6.27 Bn -
2 Stryker 128.89 Bn 126.01 Bn 3.81 Bn -
3 Medtronic 108.48 Bn 99.26 Bn 6.41 Bn -
4 Boston Scientific 68.51 Bn 67.05 Bn 3.61 Bn 1.12 Bn
5 Edwards Lifesciences 48.32 Bn 44.65 Bn 1.29 Bn -
6 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.23 Bn 25.95 Bn 1.98 Bn -
8 Smith & Nephew 26.90 Bn 26.32 Bn - -
9 Koninklijke Philips 24.47 Bn 21.35 Bn 2.07 Bn -
10 Steris 21.46 Bn 21.02 Bn 697.10 Mn 509.50 Mn

Historic Data

Download Data
DateValue
Dec 31, 2017 -806.54 Mn
Dec 31, 2016 -800.08 Mn